SMB·BIO

Ginkgo biloba extract shows clear benefit for intermittent claudication patients

by
조 문술
Published : Nov. 19, 2026 - 14:38:43
    • Copy Completed!

View Korean Original

Seoul St. Mary's Hospital research team analyzes clinical trial data published since 2013

Ginkgo biloba extract significantly improves walking ability in patients with intermittent claudication by enhancing peripheral blood flow, a new study shows.

A research team led by Professors Park Soon-chul and Oh Haeng-jin at Seoul St. Mary's Hospital published the meta-analysis findings in the Journal of Clinical Medicine.

The study is a meta-analysis incorporating the latest clinical trial results published after the 2013 Cochrane Review. Ginkgo biloba extract has long been used in intermittent claudication patients based on its mechanisms of improving peripheral blood flow and exerting antioxidant effects.

The research team systematically reviewed clinical trials on ginkgo biloba extract for intermittent claudication in patients with peripheral artery disease. They conducted a pooled analysis of 14 randomized, double-blind, placebo-controlled clinical trials covering 893 patients in total, comparing ginkgo biloba extract against a placebo, and evaluated the clinical evidence for its efficacy and safety.

Peripheral artery disease is a condition in which blood flow decreases due to atherosclerotic occlusion of the lower-limb arteries, with intermittent claudication as its hallmark symptom. The condition causes pain in the calves, thighs and buttocks during walking that subsides with rest. Treatment efficacy is generally assessed using walking performance indicators such as maximum walking distance.

Because walking distance measurement conditions varied across studies, the research team analyzed outcomes using energy expenditure during walking (kcal) as a common metric. Patients who received ginkgo biloba extract showed a statistically significant improvement in absolute claudication distance compared with the placebo group (mean difference: 3.50 kcal, p=0.049), corresponding to an improvement of approximately 60 meters in actual walking distance.

In the 24-week treatment group, the improvement over placebo was even more pronounced. Seven studies examining 24-week treatment found that maximum walking distance improved by 4.67 kcal compared with the placebo group (p<0.001), equivalent to an improvement of approximately 81 meters in actual walking distance. The research team attributed these results to the cumulative long-term effects of ginkgo biloba extract on blood flow improvement, antioxidant activity and microcirculation enhancement.

"This study is meaningful in that it reconfirmed the previously observed improvement in walking distance in a larger patient population and further solidified the clinical evidence," Professor Oh said.


freiheit@heraldcorp.com
This content was produced with the assistance of AI translation services.

MOST READ